Nasdaq: EXEL
Exelixis insiders
The officers, directors and 10% owners of Exelixis, Inc. who hold the most stock, valued at the live EXEL price.
$65.83
EXEL today −$2.5M (−3.60%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 17
- Their EXEL stock
- $759M
- Market value
- $16.87B
- Held by ranked insiders
- 4.50%
Insiders by value of EXEL holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Michael Morrissey | President and CEO | 5,264,343 | $347M | 2.05% | 615th |
| 2 | Stelios Papadopoulos | Director | 1,197,595 | $78.8M | 0.47% | 1638th |
| 3 | Christopher J. Senner | EVP and CFO | 955,040 | $62.9M | 0.37% | 2162nd |
| 4 | Jeffrey Hessekiel | EVP & General Counsel | 694,395 | $45.7M | 0.27% | 2526th |
| 5 | Dana Aftab | EVP, Research and Development | 600,576 | $39.5M | 0.23% | 3042nd |
| 6 | Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 465,393 | $30.6M | 0.18% | 3705th |
| 7 | Peter Lamb | EVP, Scientific Strategy & CSO | 428,063 | $28.2M | 0.17% | 3983rd |
| 8 | Lance Willsey | Director | 424,415 | $27.9M | 0.17% | 3636th |
| 9 | Patrick J. Haley | EVP, Commercial | 381,177 | $25.1M | 0.15% | 4364th |
| 10 | Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | 307,654 | $20.3M | 0.12% | 5143rd |
| 11 | Jack L. Wyszomierski | Director | 284,384 | $18.7M | 0.11% | 5029th |
| 12 | George Poste | Director | 127,199 | $8.4M | <0.1% | 4534th |
| 13 | Brenda Hefti | SVP and General Counsel | 112,289 | $7.4M | <0.1% | 10968th |
| 14 | Maria C. Freire | Director | 109,186 | $7.2M | <0.1% | 8912th |
| 15 | Vincent T. Marchesi | Director | 93,989 | $6.2M | <0.1% | 12489th |
| 16 | Jacqueline Wright | Director | 51,756 | $3.4M | <0.1% | 13935th |
| 17 | Alan M. Garber | Director | 35,703 | $2.4M | <0.1% | 12510th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Exelixis; see each profile for the filing.